Crohn’s disease or Crohn’s diseases?

Por Arnott, I D R, Satsangi, J
Publicado em 2003

Multiple liver lesions in a smoker

Por Sharkey, J, Palmer, K R, Arnott, I D R, Glancy, S
Publicado em 2007

Toll-like receptor 4 gene in IBD: further evidence for genetic heterogeneity in Europe

Por Arnott, I D R, Ho, G-T, Nimmo, E R, Satsangi, J
Publicado em 2005

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial

Por Probert, C S J, Hearing, S D, Schreiber, S, Kühbacher, T, Ghosh, S, Arnott, I D R, Forbes, A
Publicado em 2003

Authors' reply

Por Satsangi, J, Noble, C, Arnott, I D R, Russell, R K, Nimmo, E R
Publicado em 2006

DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population

Por Noble, C L, Nimmo, E R, Drummond, H, Smith, L, Arnott, I D R, Satsangi, J
Publicado em 2005

Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations

Por WALKER, L J, ALDHOUS, M C, DRUMMOND, H E, SMITH, B R K, NIMMO, E R, ARNOTT, I D R, SATSANGI, J
Publicado em 2004